Blogs

 

Latest News

Searching for posts in the month of: September 2020


Thumbnail for The ASI Newsletter September 2020 edition is out now!

Friday September 18, 2020

Please click here to visit our Newsletter page and download your copy of the September 2020 ASI Newsletter.
More...


Thumbnail for Introducing the new ASI Career Advancement Awards

Tuesday September 08, 2020

  Introducing the new ASI Career Advancement Awards Application round:  September 8th - October 5th 2020 for research undertaken in Jan - Dec 2021 Given the challenging times we are in and the limited opportunity for international travel, ASI will be repurposing funds originally committed to the second 2020 round of ITA's and the Gordon Ada Senior Travel Awards.  These new career advancement awards will allow for a broader scope and flexibility to apply for support as needed, similar to the Jared Purton Award. Application rounds for the following ...
More...


Thumbnail for Introducing the new ASI Carer Awards - COVID support

Tuesday September 08, 2020

  Introducing the new ASI Carer Awards - COVID support Application round:  September 8th - October 5th 2020 to support caring costs in 2020 or 2021 ASI is acutely aware of the pressure that COVID-19 restrictions have placed on carers, limiting access to care support from both formal and informal mechanisms. To support members of our community whose carer responsibilities have impacted or will impact on their career progression, we invite applications to the 2020 ASI Carer Awards- COVID support.  We have created these awards by repurposing ...
More...


Thumbnail for Introducing Nanostring as our newest ASI Sustaining Member

Wednesday September 02, 2020

We welcome our new ASI Sustaining Member: Nanostring   Our ASI Sustaining Members recognise the importance of supporting ASI and Immunology researchers in Australia and New Zealand.  We are grateful and proud to introduce our newest ASI Sustaining Member: Nanostring. About Nanostring NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.   Nanostring's commitment to research The Singapore Immunology Network (SIgN) & NanoString, in collaboration with Illumina, co-sponsor a research award ...
More...

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B